Mark Kris, MD: Choosing a Treatment in NSCLC

Mark Kris, MD: Choosing a Treatment in NSCLC

How to Select Treatment for Resectable Stage III Lung CancerПодробнее

How to Select Treatment for Resectable Stage III Lung Cancer

Dr. Mark Kris on Immunotherapy and Frontline Options for Patients With NSCLCПодробнее

Dr. Mark Kris on Immunotherapy and Frontline Options for Patients With NSCLC

Mark Kris, MD: Antiangiogenic Therapy in NSCLCПодробнее

Mark Kris, MD: Antiangiogenic Therapy in NSCLC

Mark Kris, MD: Lacking Actionable Mutations in NSCLCПодробнее

Mark Kris, MD: Lacking Actionable Mutations in NSCLC

Mark Kris on New Therapies for Lung CancerПодробнее

Mark Kris on New Therapies for Lung Cancer

Choosing a lung cancer treatment facility videoПодробнее

Choosing a lung cancer treatment facility video

Transforming Cancer Care with Cognitive Solutions: MSK-IBM Watson Oncology by Mark Kris, MDПодробнее

Transforming Cancer Care with Cognitive Solutions: MSK-IBM Watson Oncology by Mark Kris, MD